rabbit polyclonal anti nrf1  (Proteintech)

Journal: Cell Genomics

Article Title: A highland-adaptation variant near MCUR1 reduces its transcription and attenuates erythrogenesis in Tibetans

doi: 10.1016/j.xgen.2025.100782

Figure Lengend Snippet:

Article Snippet: Rabbit polyclonal anti-NRF1 , Proteintech , Cat#12482-1-AP; RRID: AB_2282876.

Techniques: Recombinant, Modification, Protease Inhibitor, Luminescence Assay, DNA Extraction, Multiplex Assay, Reporter Assay, Reverse Transcription, SYBR Green Assay, Electrophoresis, Mobility Shift, Transfection, Chromatin Immunoprecipitation, Mutagenesis, Enzyme-linked Immunosorbent Assay, Purification, Sequencing, RNA Sequencing, Gene Expression, Expressing, Real-time Polymerase Chain Reaction, Plasmid Preparation, Software

Journal: Oxidative Medicine and Cellular Longevity

Article Title: NRF1 and NRF2 mRNA and Protein Expression Decrease Early during Melanoma Carcinogenesis: An Insight into Survival and MicroRNAs

doi: 10.1155/2019/2647068

Figure Lengend Snippet: Antibodies used in immunohistochemical staining and western blot.

Article Snippet: NRF1 , Rabbit polyclonal anti-NRF1 (C-terminal) , 1 : 2500 , , , , , Sigma, HPA065424 , Not reported.

Techniques: Immunohistochemical staining, Staining, Western Blot, Incubation

Journal: Oxidative Medicine and Cellular Longevity

Article Title: NRF1 and NRF2 mRNA and Protein Expression Decrease Early during Melanoma Carcinogenesis: An Insight into Survival and MicroRNAs

doi: 10.1155/2019/2647068

Figure Lengend Snippet: Primers used in qPCR.

Article Snippet: NRF1 , Rabbit polyclonal anti-NRF1 (C-terminal) , 1 : 2500 , , , , , Sigma, HPA065424 , Not reported.

Techniques: Amplification, Inhibition

Journal: Oxidative Medicine and Cellular Longevity

Article Title: NRF1 and NRF2 mRNA and Protein Expression Decrease Early during Melanoma Carcinogenesis: An Insight into Survival and MicroRNAs

doi: 10.1155/2019/2647068

Figure Lengend Snippet: Immunohistochemical and mRNA expression of NRF1 and NRF2. (a) Boxplots representing the Histoscore of the immunohistochemical expression of NRF1 and p40-NRF2 and relative mRNA levels of NRF1 and NRF2 from paraffin-embedded patient samples, (b) expression levels of NRF1 and NRF2 mRNA from representative cell culture samples, and (c) Pooled GEO data from three different cDNA microarray studies including the expression levels of NFE2L1 and NFE2L2 (NRF1 and NRF2). Outliers of the figures are reported.

Article Snippet: NRF1 , Rabbit polyclonal anti-NRF1 (C-terminal) , 1 : 2500 , , , , , Sigma, HPA065424 , Not reported.

Techniques: Immunohistochemical staining, Expressing, Cell Culture, Microarray

Journal: Oxidative Medicine and Cellular Longevity

Article Title: NRF1 and NRF2 mRNA and Protein Expression Decrease Early during Melanoma Carcinogenesis: An Insight into Survival and MicroRNAs

doi: 10.1155/2019/2647068

Figure Lengend Snippet: Protein expression of NRF1 and p40-NRF2 in western blot, fractionated cell lysates from IPC-298 melanoma cells, β -actin, and PCNA (proliferating cell nuclear antigen) serve as loading and fractioning controls. NRF1 detected with an antibody targeting N-terminal domain is expressed in membranous fraction, and NRF1 detected with an antibody targeting C-terminal domain is expressed mostly in the nuclear fraction. p40-NRF2 is expressed in the cytoplasmic, membranous, and nuclear fractions.

Article Snippet: NRF1 , Rabbit polyclonal anti-NRF1 (C-terminal) , 1 : 2500 , , , , , Sigma, HPA065424 , Not reported.

Techniques: Expressing, Western Blot

Journal: Oxidative Medicine and Cellular Longevity

Article Title: NRF1 and NRF2 mRNA and Protein Expression Decrease Early during Melanoma Carcinogenesis: An Insight into Survival and MicroRNAs

doi: 10.1155/2019/2647068

Figure Lengend Snippet: Immunohistochemical expression in patient samples. (a-d) NRF1 C-terminal antibody, benign naevus, dysplastic naevus, primary melanoma, and metastatic melanoma from a lymph node, respectively, diaminobenzidine and haematoxylin, (e-h) NRF1 N-terminal antibody, benign naevus, dysplastic naevus, primary melanoma, and metastatic melanoma from a lymph node, respectively, Fast Red and haematoxylin, and (i-l) p40-NRF2, benign naevus, dysplastic naevus, primary melanoma, and metastatic melanoma from a lymph node, respectively, diaminobenzidine and haematoxylin.

Article Snippet: NRF1 , Rabbit polyclonal anti-NRF1 (C-terminal) , 1 : 2500 , , , , , Sigma, HPA065424 , Not reported.

Techniques: Immunohistochemical staining, Expressing

Journal: Oxidative Medicine and Cellular Longevity

Article Title: NRF1 and NRF2 mRNA and Protein Expression Decrease Early during Melanoma Carcinogenesis: An Insight into Survival and MicroRNAs

doi: 10.1155/2019/2647068

Figure Lengend Snippet: (a) High nuclear NRF1 expression (cut-off 32.5 based on ROC analysis) associated with worse melanoma-specific survival in those patients without nodal metastases at the time of diagnosis. (b) NRF1 did not separate the groups in cases with nodal metastases at the time of diagnosis. (c) High nuclear p40-NRF2 expression (highest quartile in Histoscore) predicted poor outcome within the patients with M0 disease at the time of diagnosis.

Article Snippet: NRF1 , Rabbit polyclonal anti-NRF1 (C-terminal) , 1 : 2500 , , , , , Sigma, HPA065424 , Not reported.

Techniques: Expressing

Journal: Cells

Article Title: A Combination Therapy of Urolithin A+EGCG Has Stronger Protective Effects than Single Drug Urolithin A in a Humanized Amyloid Beta Knockin Mice for Late-Onset Alzheimer’s Disease

doi: 10.3390/cells11172660

Figure Lengend Snippet: Summary of q RT-PCR oligonucleotide primers used in measuring mRNA expression in mitochondrial structural, biogenesis, synaptic genes and autophagy and mitophagy genes.

Article Snippet: NRF1 Rabbit polyclonal (#NBP1-77822) 1:300 , Novus Biological, Littleton, CO , Donkey anti-rabbit HRP 1:10,000 , GE Healthcare Amersham, Piscataway, NJ.

Techniques: Expressing, Sequencing

Journal: Cells

Article Title: A Combination Therapy of Urolithin A+EGCG Has Stronger Protective Effects than Single Drug Urolithin A in a Humanized Amyloid Beta Knockin Mice for Late-Onset Alzheimer’s Disease

doi: 10.3390/cells11172660

Figure Lengend Snippet: Summary of antibody dilutions and conditions used in the immunofluorescence analysis of mitochondrial dynamics, mitochondrial biogenesis, synaptic mitophagy and autophagy proteins in mitophagy enhancer-treated and -untreated hAbKI mice.

Article Snippet: NRF1 Rabbit polyclonal (#NBP1-77822) 1:300 , Novus Biological, Littleton, CO , Donkey anti-rabbit HRP 1:10,000 , GE Healthcare Amersham, Piscataway, NJ.

Techniques: Immunofluorescence

Journal: Cells

Article Title: A Combination Therapy of Urolithin A+EGCG Has Stronger Protective Effects than Single Drug Urolithin A in a Humanized Amyloid Beta Knockin Mice for Late-Onset Alzheimer’s Disease

doi: 10.3390/cells11172660

Figure Lengend Snippet: Summary of antibody dilutions and conditions used in the immunoblotting analysis of mitochondrial dynamics, mitochondrial biogenesis, synaptic mitophagy and autophagy proteins in mitophagy enhancer-treated and -untreated hAbKI mice.

Article Snippet: NRF1 Rabbit polyclonal (#NBP1-77822) 1:300 , Novus Biological, Littleton, CO , Donkey anti-rabbit HRP 1:10,000 , GE Healthcare Amersham, Piscataway, NJ.

Techniques: Western Blot

Journal: Cells

Article Title: A Combination Therapy of Urolithin A+EGCG Has Stronger Protective Effects than Single Drug Urolithin A in a Humanized Amyloid Beta Knockin Mice for Late-Onset Alzheimer’s Disease

doi: 10.3390/cells11172660

Figure Lengend Snippet: Summary of mRNA fold changes comparison in Urolithin A-treated hAbKI mice and Urolithin A+EGCG treated hAbKI mice.

Article Snippet: NRF1 Rabbit polyclonal (#NBP1-77822) 1:300 , Novus Biological, Littleton, CO , Donkey anti-rabbit HRP 1:10,000 , GE Healthcare Amersham, Piscataway, NJ.

Techniques: Comparison

Journal: Cells

Article Title: A Combination Therapy of Urolithin A+EGCG Has Stronger Protective Effects than Single Drug Urolithin A in a Humanized Amyloid Beta Knockin Mice for Late-Onset Alzheimer’s Disease

doi: 10.3390/cells11172660

Figure Lengend Snippet: Immunoblotting analysis of mitochondrial biogenesis. ( A ) Representative immunoblots for mitochondrial biogenesis proteins in hAbKI mice and treated hAbKI mice with Urolithin A and EGCG. ( B ) Quantitative-densitometry analysis of mitochondrial biogenesis proteins PGC1α, NRF1, NRF2 and TFAM. PGC1α, NRF1, NRF2 and TFAM were significantly increased in the treated hAbKI mice Urolithin A and EGCG.

Article Snippet: NRF1 Rabbit polyclonal (#NBP1-77822) 1:300 , Novus Biological, Littleton, CO , Donkey anti-rabbit HRP 1:10,000 , GE Healthcare Amersham, Piscataway, NJ.

Techniques: Western Blot

Journal: Cells

Article Title: A Combination Therapy of Urolithin A+EGCG Has Stronger Protective Effects than Single Drug Urolithin A in a Humanized Amyloid Beta Knockin Mice for Late-Onset Alzheimer’s Disease

doi: 10.3390/cells11172660

Figure Lengend Snippet: Immunofluorescence analysis of hippocampal mitochondrial biogenesis proteins in seven-month-old hAbKI mice and treated hAbKI mice with Urolithin A and EGCG. ( A ) Representative immunofluorescence images and ( B ) quantitative analysis of mitochondrial biogenesis proteins, PGC1a, Nrf1, Nrf2 and TFAM in hAbKI mice and treated hAbKI mice with Urolithin A and EGCG.

Article Snippet: NRF1 Rabbit polyclonal (#NBP1-77822) 1:300 , Novus Biological, Littleton, CO , Donkey anti-rabbit HRP 1:10,000 , GE Healthcare Amersham, Piscataway, NJ.

Techniques: Immunofluorescence